Abstract
Two cannabinoids, Δ9 and cannabidiol, and several reference drugs were compared relative to their effects in a recently developed anticonvulsant test system, the after-discharge potentials of the visually evoked response; the potentials were recorded electrophysiologically from electrodes permanently mounted over the visual cortices of conscious rats. In anticonvulsant doses, trimethadione and ethosuximide produced an extensive depression of after-discharge activity, whereas diphenylhydantoin and cannabidiol exerted no such effect. In contrast, anticonvulsant doses of Δ9 and subconvulsant doses of pentylenetetrazol markedly increased after-discharge activity, which may represent a manifestation of their central nervous system excitatory properties. The data from the present study support our previously published observations from several other anticonvulsant tests that indicate the anticonvulsant characteristics of cannabidiol resemble those of diphenylhydantoin rather than those of trimethadione and that the central excitatory properties of Δ9 distinguish it from cannabidiol. The results consistently suggest that the cannabinoids will be effective against grand mal but not absence seizures.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bickford, R. G., Klass, D. W.: Sensory precipitation and reflex mechanisms. In: Basic mechanisms of the epilepsies, H. H. Jasper, A. A. Ward, Jr., and A. Pope, eds., pp. 543–573. London: Churchill 1969
Bigler, E. D.: Lateral geniculate multiple-unit activity related to Metrazol potentiated after-discharges. Electroenceph. clin. Neurophysiol. 39, 491–497 (1975)
Boyd, E. S., Boyd, E. H., Brown, L. E.: Effects of tetrahydrocannabinols on evoked responses in polysensory cortex. Ann. N. Y. Acad. Sci. 191, 100–122 (1971a)
Boyd, E. S., Boyd, E. H., Muchmore, J. S., Brown, L. E.: Effects of two tetrahydrocannabinols and of pentobarbital on corticocortical evoked responses in the squirrel monkey. J. Pharmacol. exp. Ther. 176, 480–488 (1971b)
Boyd, E. S., Boyd, E. H., Brown, L. E.: The effects of some drugs on an evoked response sensitive to tetrahydrocannabinols. J. Pharmacol. exp. Ther. 189, 748–758 (1974)
Chen, G., Portman, R.: Titration of central-nervous-system depression. Arch. Neurol. Psychiat. (Chic.) 68, 498–505 (1952)
Chen, G., Weston, J. K., Bratton, A. C., Jr.: Anticonvulsant activity and toxicity of phensuximide, methsuximide and ethosuximide. Epilepsia (Basel) 4, 66–76 (1963)
Consroe, P. F., Man, D. P.: Effects of Δ8- and Δ9-tetrahydrocannabinols. Life Sci. 13, 429–439 (1973)
Consroe, P. F., Man, D. P., Chin, L., Picchioni, A. L.: Reduction of audiogenic seizures by Δ8- and Δ9-tatrahydrocannabinols. J. Pharm. Pharmacol. 25, 764–765 (1973)
Dow, R. C., Forfar, J. C., McQueen, J. K.: The effects of some anticonvulsant drugs on cobalt-induced epilepsy. Epilepsia (Basel) 14, 203–212 (1973)
Esplin, D. W.: Synaptic system models. In: Experimental models of epilepsy—A manual for the laboratory worker, D. P. Purpura, J. K. Penry, D. M. Woodbury, D. B. Tower, and R. D. Walter, eds., pp. 224–248. New York: Raven Press 1972
Fleming, D. E., Rhodes, L. E., Wilson, C. E., Shearer, D. E.: Differential effects of convulsive drugs on photically evoked after-discharge parameters. Psychopharmacologia (Berl.) 29, 77–84 (1973)
Garriott, J. C., Forney, R. B., Hughes, F. W., Richards, A. B.: Pharmacologic properties of some cannabis related compounds. Arch. int. Pharmacodyn. 171, 425–434 (1968)
Guha, D., Pradhan, S. N.: Effects of mescaline, [Δ9]-tetrahydrocannabinols and pentobarbital on the auditory evoked responses in the cat. Neuropharmacology 13, 755–762 (1974)
Julien, R. M., Fowler, G. W., Danielson, M. G.: The effects of antiepileptic drugs on estrogen-induced electrographic spikewave discharge. J. Pharmacol. exp. Ther. 193, 647–656 (1975)
Karler, R., Cely, W., Turkanis, S. A.: The anticonvulsant activity of cannabidiol and cannabinol. Life Sci. 13, 1527–1531 (1973)
Karler, R., Cely, W., Turkanis, S. A.: Anticonvulsant properties of Δ9-tetrahydrocannabinol and other cannabinoids. Life Sci. 15, 931–947 (1974a)
Karler, R., Cely, W., Turkanis, S. A.: A study of the relative anticonvulsant and toxic activities of Δ9-tetrahydrocannabinol and its congeners. Res. Commun. chem. Path. Pharmacol. 7, 353–358 (1974b)
Karler, R., Cely, W., Turkanis, S. A.: A study of the development of tolerance to an anticonvulsant effect of Δ9-tetrahydrocannabinol and cannabidiol. Res. Commun. chem. Path. Pharmacol. 9, 23–39 (1974c)
Karler, R., Cely, W., Turkanis, S. A.: Anticonvulsant activity of Δ9-tetrahydrocannabinol and its 11-hydroxy and 8α, 11-dihydroxy metabolites in the frog. Res. Commun. chem. Path. Pharmacol. 9, 441–452 (1974d)
Karler, R., Turkanis, S. A.: The antiepileptic potential of the cannabinoids. In: The therapeutic potential of cannabis, S. Cohen and R. Stillman, eds., pp. 383–397. New York: Raven Press 1976
Kimura, D.: Multiple response of visual cortex of the rat to photic stimulation. Electroenceph. clin. Neurophysiol. 14, 115–122 (1962)
Loewe, S., Goodman, L. S.: Anticonvulsant action of marihuana-active substances. Fed. Proc. 6, 352 (1947)
Meldrum, B. S., Fariello, R. G., Puil, E. A., Derouaux, M., Naquet, R.: 212-8 and epilepsy in the photosensitive baboon, Papio papio. Epilepsia (Basel) 15, 255–264 (1974)
Mitchell, C. L., Keasling, H. H.: A comparison of three anticonvulsant testing methods. J. Pharmacol. exp. Ther. 128, 79–84 (1960)
Naquet, R., Meldrum, B. S.: Photogenic seizures in baboon. In: Experimental models of epilepsy, D. P. Purpura, J. K. Penry, D. B. Tower, D. M. Woodbury, and R. D. Walter, eds., pp. 373–406. New York: Raven Press 1972
Petty, W. C., Karler, R.: The influence of aging on the activity of anticonvulsant drugs. J. Pharmacol. exp. Ther. 150, 443–448 (1965)
Segal, M.: Central implantation of cannabinoids: Induction of epileptiform discharges. Europ. J. Pharmacol. 27, 40–45 (1974)
Shearer, D. E., Fleming, D. E., Bigler, E. D., Wilson, C. E.: Suppression of photically evoked after-discharge bursting following administration of anticonvulsants in waking rats. Pharmacol. Biochem. Behav. 2, 839–842 (1974)
Snedecor, G. W., Cochran, W. G.: Statistical Methods, 6 ed. Ames, Iowa: Iowa State University Press 1967
Sofia, R. D., Solomon, T. A., Barry, III, H.: The anticonvulsant activity of Δ9-tetrahydrocannabinol in mice. Pharmacologist 13, 246 (1971)
Sofia, R. D., Solomon, T. A., Barry, III, H.: Anticonvulsant activity of Δ9-tetrahydrocannabinol compared with three other drugs. Europ. J. Pharmacol. 35, 7–16 (1976)
Stadnicki, S. W., Schaeppi, U., Rosenkrantz, H., Braude, M. C.: 212-11: Subcortical spike bursts and motor manifestations in a Fischer rat treated orally for 109 days. Life Sci. 14, 463–472 (1974)
Swinyard, E. A., Brown, W. C., Goodman, L. S.: Comparative assays of antiepileptic drugs in mice and rats. J. Pharmacol. exp. Ther. 106, 319–330 (1952)
Thomson, T. D., Turkanis, S. A.: Barbiturate-induced transmitter release at a frog neuromuscular junction. Brit. J. Pharmacol. 48, 48–58 (1973)
Turkanis, S. A., Cely, W., Olsen, D. M., Karler, R.: Anticonvulsant properties of cannabidiol. Res. Commun. chem. Path. Pharmacol. 8, 231–246 (1974)
Weiss, G. K., Feeny, D. M., Spiker, M.: Effect of Δ9-THC on physical symptoms and EEG in the naturally epileptic beagle. Fed. Proc. 35, 644 (1976)
Wikinson, D. M., Halpern, L. M.: Effects of selected anticonvulsants on conjugated estrogen-induced epileptiform activity. Proc. West. Pharmacol. Soc. 17, 87–91 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Turkanis, S.A., Chiu, P., Borys, H.K. et al. Influence of Δ9 and cannabidiol on photically evoked after-discharge potentials. Psychopharmacology 52, 207–212 (1977). https://doi.org/10.1007/BF00439112
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00439112